Inspire Medical Systems Q2 2024 Revenue Surges by 30%by Mark Eisenberg 07.08.2024Inspire Medical Systems reports a 30% revenue increase in Q2 2024, with net income of $9.8 million, and raises full-year ...
Nexalin Technology vs. Rivals: Volatility & Ownership Insightsby Mark Eisenberg 16.06.2024Nexalin Technology: 0.7% institutional, 7% insider ownership. Beta of 5.13 reveals high volatility; rivals surpass in 8 of 10 factors. ...
Nexalin Tech’s Short Interest Drops 16.9% Amid Volatilityby Terry Bingman 16.06.2024Nexalin shares are 1% shorted; 52-week range $0.25-$3.40. Market cap: $6.69M, PE ratio: -1.36, beta: 5.13. Qtr EPS: -$0.10; ROE: ...
Nalu Medical Secures $85M in Series E Fundingby Mark Eisenberg 06.03.2024Nalu Medical, a Carlsbad-based company, raised $20M in Series E funding for their innovative solutions in treating chronic neuropathic pain. ...